Lumos Pharma Inc. | NLNK - Pre Tax Profit

Newlink Genetics reported $-8260000 in Pre-Tax Profit for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Pre Tax Profit Change
Agenus AGEN:US USD -74102000 17.39M
Capricor Therapeutics CAPR:US USD -7721000 1.35M
Celldex Therapeutics CLDX:US USD -26487000 297K
Eli Lilly And LLY:US USD 2.04B 38.3M
Idera Pharmaceuticals IDRA:US USD 9.14M 14.44M
Intrexon XON:US USD -22168000 14.47M
Merk MRK:US USD 4.89B 560M
Nektar Therapeutics NKTR:US USD -56544000 2.66M
Newlink Genetics NLNK:US USD -8260000 1.01M
Pfizer PFE:US USD 7.38B 3.3B
Prothena PRTA:US USD 3.34M 51.76M
Sarepta Therapeutics SRPT:US USD -101306000 155.11M
Vascular Biogenics VBLT:US USD -9170000 264K
YTE INCY:US USD 178.62M 401K